276 related articles for article (PubMed ID: 11279118)
21. Properties of MEKs, the kinases that phosphorylate and activate the extracellular signal-regulated kinases.
Zheng CF; Guan KL
J Biol Chem; 1993 Nov; 268(32):23933-9. PubMed ID: 8226933
[TBL] [Abstract][Full Text] [Related]
22. Phosphorylation of MAP kinases by MAP/ERK involves multiple regions of MAP kinases.
Wilsbacher JL; Goldsmith EJ; Cobb MH
J Biol Chem; 1999 Jun; 274(24):16988-94. PubMed ID: 10358048
[TBL] [Abstract][Full Text] [Related]
23. The dual specificity phosphatases M3/6 and MKP-3 are highly selective for inactivation of distinct mitogen-activated protein kinases.
Muda M; Theodosiou A; Rodrigues N; Boschert U; Camps M; Gillieron C; Davies K; Ashworth A; Arkinstall S
J Biol Chem; 1996 Nov; 271(44):27205-8. PubMed ID: 8910287
[TBL] [Abstract][Full Text] [Related]
24. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis.
Xia Z; Dickens M; Raingeaud J; Davis RJ; Greenberg ME
Science; 1995 Nov; 270(5240):1326-31. PubMed ID: 7481820
[TBL] [Abstract][Full Text] [Related]
25. MEKK1 binds directly to the c-Jun N-terminal kinases/stress-activated protein kinases.
Xu S; Cobb MH
J Biol Chem; 1997 Dec; 272(51):32056-60. PubMed ID: 9405400
[TBL] [Abstract][Full Text] [Related]
26. Identification of c-Jun NH2-terminal protein kinase (JNK)-activating kinase 2 as an activator of JNK but not p38.
Lu X; Nemoto S; Lin A
J Biol Chem; 1997 Oct; 272(40):24751-4. PubMed ID: 9312068
[TBL] [Abstract][Full Text] [Related]
27. Differential activation of the ERK, JNK, and p38 mitogen-activated protein kinases by CD40 and the B cell antigen receptor.
Sutherland CL; Heath AW; Pelech SL; Young PR; Gold MR
J Immunol; 1996 Oct; 157(8):3381-90. PubMed ID: 8871635
[TBL] [Abstract][Full Text] [Related]
28. A novel human STE20-related protein kinase, HGK, that specifically activates the c-Jun N-terminal kinase signaling pathway.
Yao Z; Zhou G; Wang XS; Brown A; Diener K; Gan H; Tan TH
J Biol Chem; 1999 Jan; 274(4):2118-25. PubMed ID: 9890973
[TBL] [Abstract][Full Text] [Related]
29. Activation of mitogen-activated protein kinase pathways by cyclic GMP and cyclic GMP-dependent protein kinase in contractile vascular smooth muscle cells.
Komalavilas P; Shah PK; Jo H; Lincoln TM
J Biol Chem; 1999 Nov; 274(48):34301-9. PubMed ID: 10567406
[TBL] [Abstract][Full Text] [Related]
30. Regulation of p73 by c-Abl through the p38 MAP kinase pathway.
Sanchez-Prieto R; Sanchez-Arevalo VJ; Servitja JM; Gutkind JS
Oncogene; 2002 Jan; 21(6):974-9. PubMed ID: 11840343
[TBL] [Abstract][Full Text] [Related]
31. Stress-activated kinase pathway alteration is a frequent event in bladder cancer.
Otto KB; Acharya SS; Robinson VL
Urol Oncol; 2012; 30(4):415-20. PubMed ID: 22154358
[TBL] [Abstract][Full Text] [Related]
32. Cloning of DPK, a novel dendritic cell-derived protein kinase activating the ERK1/ERK2 and JNK/SAPK pathways.
Zhang W; Chen T; Wan T; He L; Li N; Yuan Z; Cao X
Biochem Biophys Res Commun; 2000 Aug; 274(3):872-9. PubMed ID: 10924369
[TBL] [Abstract][Full Text] [Related]
33. Activation of p38 mitogen-activated protein kinase by PYK2/related adhesion focal tyrosine kinase-dependent mechanism.
Pandey P; Avraham S; Kumar S; Nakazawa A; Place A; Ghanem L; Rana A; Kumar V; Majumder PK; Avraham H; Davis RJ; Kharbanda S
J Biol Chem; 1999 Apr; 274(15):10140-4. PubMed ID: 10187797
[TBL] [Abstract][Full Text] [Related]
34. Discordance between the binding affinity of mitogen-activated protein kinase subfamily members for MAP kinase phosphatase-2 and their ability to activate the phosphatase catalytically.
Chen P; Hutter D; Yang X; Gorospe M; Davis RJ; Liu Y
J Biol Chem; 2001 Aug; 276(31):29440-9. PubMed ID: 11387337
[TBL] [Abstract][Full Text] [Related]
35. Cross-talk between JNK/SAPK and ERK/MAPK pathways: sustained activation of JNK blocks ERK activation by mitogenic factors.
Shen YH; Godlewski J; Zhu J; Sathyanarayana P; Leaner V; Birrer MJ; Rana A; Tzivion G
J Biol Chem; 2003 Jul; 278(29):26715-21. PubMed ID: 12738796
[TBL] [Abstract][Full Text] [Related]
36. Cloning and characterization of MEK6, a novel member of the mitogen-activated protein kinase kinase cascade.
Stein B; Brady H; Yang MX; Young DB; Barbosa MS
J Biol Chem; 1996 May; 271(19):11427-33. PubMed ID: 8626699
[TBL] [Abstract][Full Text] [Related]
37. Cloning of a novel mitogen-activated protein kinase kinase kinase, MEKK4, that selectively regulates the c-Jun amino terminal kinase pathway.
Gerwins P; Blank JL; Johnson GL
J Biol Chem; 1997 Mar; 272(13):8288-95. PubMed ID: 9079650
[TBL] [Abstract][Full Text] [Related]
38. Selective activation of p38 mitogen-activated protein (MAP) kinase isoforms by the MAP kinase kinases MKK3 and MKK6.
Enslen H; Raingeaud J; Davis RJ
J Biol Chem; 1998 Jan; 273(3):1741-8. PubMed ID: 9430721
[TBL] [Abstract][Full Text] [Related]
39. Activation and role of MAP kinase-dependent pathways in retinal pigment epithelium cells: JNK1, P38 kinase, and cell death.
Hecquet C; Lefevre G; Valtink M; Engelmann K; Mascarelli F
Invest Ophthalmol Vis Sci; 2003 Mar; 44(3):1320-9. PubMed ID: 12601065
[TBL] [Abstract][Full Text] [Related]
40. Synergistic activation of stress-activated protein kinase 1/c-Jun N-terminal kinase (SAPK1/JNK) isoforms by mitogen-activated protein kinase kinase 4 (MKK4) and MKK7.
Fleming Y; Armstrong CG; Morrice N; Paterson A; Goedert M; Cohen P
Biochem J; 2000 Nov; 352 Pt 1(Pt 1):145-54. PubMed ID: 11062067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
